Which closed-end funds own Halozyme Therapeutics Inc?
5 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $14.7M. Security type: common equity. Country: United States. CUSIP 40637H109 · ISIN US40637H1095 · ticker HALO.
Holdings are historical filings (report dates Jun 30, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| GRX Gabelli Healthcare & WellnessRx Trust | Healthcare | 1.48% | $3.4M | 43,200 sh | $228M | NAV unavailable | Jun 30, 2026 |
| CPZ Calamos Long/Short Equity & Dynamic Income Trust | U.S. Equity | 1.37% | $3.5M | 43,000 sh | $259M | 15.5% discount | Jul 31, 2026 |
| ASG Liberty All Star Growth Fund | U.S. Equity | 0.65% | $2.6M | 33,300 sh | $398M | 12.8% discount | Jun 30, 2026 |
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.46% | $4.9M | 63,226 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| GGZ Gabelli Global Small & Mid Cap Value Trust | Global Equity | 0.14% | $235K | 3,000 sh | $165M | 11.6% discount | Jun 30, 2026 |
5 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: HALOZYME THERAPEUTICS INC.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Halozyme Therapeutics in | debt security | 10 |
| Halozyme Therapeutics Inc | debt security | 5 |
| Halozyme Therapeutics Inc | debt security | 2 |
Issuer-level search for “HALO” → · Compare two funds’ portfolios →